2025 Regular Session • Kentucky Legislature
HB772: AN ACT relating to pharmaceutical manufacturers.
Legislative Summary
Amend KRS 315.400 to amend the definition of "transaction" to include pharmaceutical manufacturers.
Demographic Impact
Overall analysis of equity impact
70% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
2/19/2025
introduced in House
House of Representatives
2/19/2025
to Committee on Committees (H)
House of Representatives
2/27/2025
to Health Services (H)
House of Representatives
Status Information
Current Status
Introduced(2/19/2025)
Chamber
House of Representatives
Committee
Health Services(House of Representatives)
Sponsors
Republican: 1
Primary Sponsor
Amy Neighbors
Republican